Furthermore, miR-483-5p targeting TIMP metallopeptidase inhibitor 2 (TIMP2) promotes atherosclerosis development and endothelial dysfunction by inhibiting autophagy. The gene discussed is TIMP2; the disease is endothelial dysfunction.